Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice

Diabetes, Obesity and Metabolism

Volumn 5, Issue 5, 2003, Pages 317-324

  Hwang, I K ^a   Go, V L W ^a   Harris, Diane M ^a   Yip, I ^a   Kang, K W ^b   Song, M K ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Korea Institute of Science and Technology Information (KISTI)   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclo (his pro); Diabetes mellitus; Glucose utilization; Insulin; L histidine; Zinc

Indexed keywords

ANTIDIABETIC AGENT; CYCLO(HISTIDYLPROLINE); DRINKING WATER; GLUCOSE; HISTIDINE; INSULIN; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFICACY; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOTHESIS; MALE; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST;

EID: 0141540443     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2003.00281.x     Document Type: Article

References (49)

1. Song MK, Rosenthal MJ, Kang KW et al. Animal prostate extract ameliorates diabetic symptoms by stimulating intestinal zinc absorption in rats. Diabet Res 1996; 31: 157-170.
2. Song MK, Rosenthal MJ, Naliboff BD, Phanumas L, Kang KW. Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus. Metabolism 1998; 47: 39-43.
3. Song MK, Rosenthal MJ, Hong S et al. Synergistic antidiabetic activities of zinc, cyclo (his-pro) and arachidonic acid. Metabolism 2001; 50: 53-59.
4. 2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes. J Biol Chem 1989; 264: 16118-16122.
5. Tang X, Shay NF. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J Nutr 2001; 131: 1414-1420.
6. Huber AM, Gershoff SN. Effect of zinc deficiency in rats on insulin release from the pancreas. J Nutr 1973; 103: 1739-1744.
7. Chausmer AB. Zinc, insulin and diabetes. J Am Coll Nutr 1998; 17: 109-115.
8. Hendricks DG, Mahoney AW. Glucose tolerance in zinc-deficient rats. J Nutr 1972; 102: 1079-1084.
9. Chooi MK, Todd JK, Boyd ND. Influence of age and sex on plasma zinc levels in normal and diabetic individuals. Nutr Metab 1976; 20: 135-142.
10. Lau AL, Failla ML. Urinary excretion of zinc, copper and iron in the streptozotocin-diabetic rat. J Nutr 1984; 114: 224-233.
11. Aguilar MV, Laborda JM, Martinez-Para MC et al. Effect of diabetes on the tissular Zn/Cu ratio. J Trace Elem Med Biol 1998; 12: 155-158.
12. Terres-Martos C, Navarro-Alarcon M, Martin-Lagos F et al. Serum zinc and copper concentrations and Cu/Zn ratios in patients with hepatopathies or diabetes. J Trace Elem Med Biol 1998; 12: 44-49.
13. Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1983; 75: 273-277.
14. Ghishan FK, Greene HL. Intestinal transport of zinc in the diabetic rat. Life Sci 1983; 32: 1735-1741.
15. Johnson WT, Canfield WK. Intestinal absorption and excretion of zinc in streptozotocin-diabetic rats as affected by dietary zinc and protein. J Nutr 1985; 115: 1217-1227.
16. 65Zn absorption in patients with insulin-dependent diabetes mellitus assessed by whole-body counting technique. Clin Chim Acta 1990; 189: 13-18.
17. Begin-Heick N, Dalpe-Scott M, Rowe J, Heick HM. Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 1985; 34: 179-184.
18. Kennedy ML, Failla ML. Zinc metabolism in genetically obese (ob/ob) mice. J Nutr 1987; 117: 886-893.
19. Sjogren A, Floren CH, Nilsson A. Magnesium, potassium and zinc deficiency in subjects with type II diabetes mellitus. Acta Med Scand 1988; 224: 461-466.
20. Mantzoros CS, Prasad A, Beck FW et al. Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr 1998; 17: 270-275.
21. Blostein-Fujii A, DiSilvestro RA, Frid D, Katz C, Malarkey W. Short-term zinc supplementation in women with non-insulin-dependent diabetes mellitus: effects on plasma 5′-nucleotidase activities, insulin-like growth factor I concentrations, and lipoprotein oxidation rates in vitro. Am J Clin Nutr 1997; 66: 639-642.
22. Singh RB, Niaz MA, Rastogi SS et al. Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 1998; 17: 564-570.
23. Brandao-Neto J, da Silva CA, Figueiredo NB et al. Lack of acute zinc effects in glucose metabolism in healthy and insulin-dependent diabetes mellitus patients. Biometals 1999; 12: 161-165.
24. Chen MD, Liou SJ, Lin PY et al. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 1998; 61: 303-311.
25. Shisheva A, Gefel D, Shechter Y. Insulin-like effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats. Diabetes 1992; 41: 982-988.
26. Apostolova MD, Choo KH, Michalska AE, Tohyama C. Analysis of the possible protective role of metallothionein in streptozotocin-induced diabetes using metallothionein-null mice. J Trace Elem Med Biol 1997; 11: 1-7.
27. Tobia MH, Zdanowicz MM, Wingertzahn MA et al. The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat. Mol Genet Metab 1998; 63: 205-213.
28. Marchesini G, Bugianesi E, Ronchi M et al. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998; 47: 792-798.
29. Prasad C, Peterkofsky A. Demonstration of pyroglutamylpeptidase and amidase activities toward thyrotropin-releasing hormone in hamster hypothalamus extracts. J Biol Chem 1976; 251: 3229-3234.
30. Morgan WT. Human serum histidine-rich glycoprotein. I. Interactions with heme, metal ions and organic ligands. Biochim Biophys Acta 1978; 535: 319-333.
31. Borza DB, Morgan WT. Histidine-proline-rich glycoprotein as a plasma pH sensor. Modulation of its interaction with glycosaminoglycans by pH and metals. J Biol Chem 1998; 273: 5493-5499.
32. Rosenthal MJ, Hwang IK, Song MK. Effects of arachidonic acid and cycle (his-pro) on zinc transport across small intestine and muscle tissues. Life Sci 2001; 70: 337-348.
33. Jackson IM. Thyrotropin-releasing hormone. N Engl J Med 1982; 306: 145-155.
34. Yamada M, Shibusawa N, Hashida T et al. Abundance of cyclo (his-pro)-like immunoreactivity in the brain of TRH-deficient mice. Endocrinology 1999; 140: 538-541.
35. Mizuma H, Legardeur BY, Prasad C, Hilton CW. The bioactive peptide cycle (his-pro) may be absorbed following ingestion of nutritional supplements that contain it. J Am Coll Nutr 1996; 15: 175-179.
36. Hilton CW, Prasad C, Vo P, Mouton C. Food contains the bioactive peptide, cycle (his-pro). J Clin Endocrinol Metab 1992; 75: 375-378.
37. Hilton CW, Reddy S, Prasad C, Wilber JF. Change in circulating cycle (his-pro) concentrations in rats after ingestion of oral glucose compared to intravenous glucose and controls. Endocr Res 1990; 16: 139-150.
38. Hilton CW, Prasad C, Wilber JF. Acute alterations of cycle (his-pro) levels after oral ingestion of glucose. Neuropeptides 1990; 15: 55-59.
39. Mizuma H, Hilton CW, Prasad C. Levels of cyclo (his-pro) are increased in a perfused pancreas system after glucose infusion. Clin Res 1993; 41: 785A.
40. Prasad C, Mizuma H, Brock JW et al. A paradoxical elevation of brain cyclo (his-pro) levels in hyperphagic obese Zucker rats. Brain Res 1995; 699: 149-153.
41. Mori M, Iriuchijima T, Yamada M. Cyclo (his-pro) concentration. Changes in brain striatum of hyperglycemic rat. Diabetes 1988; 37: 1120-1122.
42. Wapnir RA, Khani DE, Bayne MA, Lifshitz F. Absorption of zinc by the rat ileum: effects of histidine and other low-molecular-weight ligands. J Nutr 1983; 113: 1346-1354.
43. Scholmerich J, Freudemann A, Kottgen E et al. Bioavailability of zinc from zinc-histidine complexes. I. Comparison with zinc sulfate in healthy men. Am J Clin Nutr 1987; 45: 1480-1486.
44. Hwang IK, Go VLW, Harris DM, Yip I, Song MK. Effects of arachidonic acid plus zinc on glucose disposal in genetically diabetic (ob/ob) mice. Diabetes Obes Metab 2002; 4: 124-131.
45. Scarpace PJ, Matheny M, Tumer N. Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 2001; 104: 1111-1117.
46. Chen MD, Song YM, Lin PY. Zinc may be a mediator of leptin production in humans. Life Sci 2000; 66: 2143-2149.
47. Niswender KD, Morrison CD, Clegg DJ et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003; 52: 227-231.
48. Mooney RA, Bordwell KL. Differential dephosphorylation of the insulin receptor and its 160-kDa substrate (pp160) in rat adipocytes. J Biol Chem 1992; 267: 14054-14060.
49. Brun JF, Guintrand-Hugret R, Fons C et al. Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans. Biol Trace Elem Res 1995; 47: 385-391.